MoneyWorks4Me

The total revenue surged to Rs. 9.85 millions, up 166.22% for the March 2024 quarter as against Rs. 3.70 millions during the year-ago period.Net Profit witnessed a 320.88% growth almost the double from Rs. 11.16 millions to Rs. 46.97  millions  of same quarter last year.Operating profit for the quarter ended March 2024 rose to 27.58 millions as compared to 20.48 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 9.85 3.70 166.22 38.11 37.07 2.81 38.11 37.07 2.81
Other Income 34.20 33.46 2.21 78.93 105.34 -25.07 78.93 105.34 -25.07
PBIDT 27.58 20.48 34.67 11.21 53.76 -79.15 11.21 53.76 -79.15
Interest 0.67 0.48 39.58 1.92 1.07 79.44 1.92 1.07 79.44
PBDT 26.91 12.55 114.42 9.29 44.81 -79.27 9.29 44.81 -79.27
Depreciation 0.29 0.26 11.54 1.16 1.45 -20.00 1.16 1.45 -20.00
PBT 26.62 12.29 116.60 8.13 43.36 -81.25 8.13 43.36 -81.25
TAX -20.35 1.13 -1900.88 -17.69 2.26 -882.74 -17.69 2.26 -882.74
Deferred Tax 1.19 1.13 5.31 3.86 2.26 70.80 3.86 2.26 70.80
PAT 46.97 11.16 320.88 25.82 41.10 -37.18 25.82 41.10 -37.18
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) 280.00 553.51 -49.41 29.41 145.02 -79.72 29.41 145.02 -79.72
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..